Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-086416

Chief Patient Supply Officer sold 3,096 shares at $0.91 ($2,804)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lunger John Chief Patient Supply Officer 2023-08-01 Sale −3,096 $0.91 $2,804 4,718 D: show line 1 in the form
Open-market sales · 3,096 sh · avg $0.91 · $2,804
Loading xslF345X05/tm2320966-2_4seq1.xml…